Salveen Richter
Stock Analyst at Goldman Sachs
(3.61)
# 802
Out of 5,162 analysts
208
Total ratings
45.22%
Success rate
7.5%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Maintains: Neutral | $37 → $9 | $15.53 | -42.05% | 10 | Mar 3, 2026 | |
| MRNA Moderna | Maintains: Neutral | $36 → $41 | $52.56 | -21.99% | 11 | Feb 17, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $40 → $25 | $27.85 | -10.23% | 10 | Nov 20, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $14.38 | -23.48% | 3 | Nov 5, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $21.97 | -27.17% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $71.19 | -8.70% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $18.94 | -4.96% | 9 | Sep 26, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $20.36 | +27.70% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $313.41 | +80.59% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $8.33 | +356.18% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $19 | $16.40 | +15.85% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $20.61 | -17.52% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $27.77 | +33.24% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $48.75 | -3.59% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $58.51 | +77.75% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $16.12 | +154.34% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $13.17 | -24.07% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $745.77 | +7.81% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $181.55 | +8.51% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $10.36 | +73.75% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $144.99 | -33.79% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $20.57 | +94.46% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $12.76 | -5.96% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $100.71 | -28.51% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $92.54 | -24.36% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $21.34 | +256.14% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $366.21 | -4.43% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $469.34 | +19.10% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $26.33 | -81.01% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $2.40 | +1,191.67% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $251.17 | -10.42% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.65 | +502.74% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.25 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.67 | +429.10% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $3.42 | +163.16% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $4.49 | -33.18% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.36 | +78.57% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $71.53 | -39.89% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $3.42 | -41.52% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $6.50 | +1,438.46% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $7.45 | +7,953.69% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $115.34 | -56.65% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $55.05 | -18.26% | 1 | Mar 17, 2020 |
uniQure
Mar 3, 2026
Maintains: Neutral
Price Target: $37 → $9
Current: $15.53
Upside: -42.05%
Moderna
Feb 17, 2026
Maintains: Neutral
Price Target: $36 → $41
Current: $52.56
Upside: -21.99%
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $40 → $25
Current: $27.85
Upside: -10.23%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $14.38
Upside: -23.48%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $21.97
Upside: -27.17%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $71.19
Upside: -8.70%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $18.94
Upside: -4.96%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $20.36
Upside: +27.70%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $313.41
Upside: +80.59%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $8.33
Upside: +356.18%
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $16.40
Upside: +15.85%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $20.61
Upside: -17.52%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $27.77
Upside: +33.24%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $48.75
Upside: -3.59%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $58.51
Upside: +77.75%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $16.12
Upside: +154.34%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $13.17
Upside: -24.07%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $745.77
Upside: +7.81%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $181.55
Upside: +8.51%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $10.36
Upside: +73.75%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $144.99
Upside: -33.79%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $20.57
Upside: +94.46%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $12.76
Upside: -5.96%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $100.71
Upside: -28.51%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $92.54
Upside: -24.36%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $21.34
Upside: +256.14%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $366.21
Upside: -4.43%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $469.34
Upside: +19.10%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $26.33
Upside: -81.01%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $2.40
Upside: +1,191.67%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $251.17
Upside: -10.42%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.65
Upside: +502.74%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $21.25
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $5.67
Upside: +429.10%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $3.42
Upside: +163.16%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $4.49
Upside: -33.18%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.36
Upside: +78.57%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $71.53
Upside: -39.89%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $3.42
Upside: -41.52%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $6.50
Upside: +1,438.46%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $7.45
Upside: +7,953.69%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $115.34
Upside: -56.65%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $55.05
Upside: -18.26%